Murj said today that it raised a $4.5 million Series A round for the platform it’s developing to manage data from implanted cardiac devices.
Santa Cruz, Calif.-based Murj said the round was led by True Ventures, joined by Social Capital and investors from a seed round. True Ventures co-founder Jon Callaghan is slated to join the Murj board in connection with the funding round, Murj said.
The company’s technology is a cloud-based, HIPAA-compliant application that’s designed to consolidate data from implanted pacemakers and defibrillators.
“As a field representative working with electrophysiologists for over a decade, I was dismayed by the inefficiency of monitoring cardiac devices,” founder & CEO Todd Butka said in prepared remarks. “From my experience at Apple (NSDQ:AAPL), I saw the tremendous potential for well-designed technology to impact the care of patients with cardiac devices. Our solution dramatically improves clinic productivity, while providing clinicians with previously unavailable insight about their clinic and patients.”
“At True, we invest in entrepreneurs that show dedication to long-term market leadership and desire to have a broad, lasting impact; Murj fits this profile perfectly,” Callaghan added. “As implantable and wearable cardiac devices proliferate, the need for advanced tools to manage the data flowing from these devices is paramount.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.